Manage Your Liver
Q:

‘ALT Focused Therapy’: A new approach to manage chronic liver diseases

‘ALT Focused Therapy’: A new approach to manage chronic liver diseases
A:

The number of deaths caused by liver cancer is constantly increasing; in 2012, liver cancer has caused more deaths than any other cancers globally. The prevalence and severity liver disease is obvious. To liver disease patients, nothing is more worrying than chronic inflammation and the possibility of developing more serious liver diseases.

 

To change the situation and treat liver disease more effectively, other than developing new medicine, reinforcing protection work and maintaining a healthy lifestyle, we should also understand the weaknesses of the current treatment and make adjustments accordingly. Let’s look at the illustration below:

 

 

We can see that the treatment process now aims to eliminate the cause of liver damage first (e.g. Hepatitis virus, fat, alcohol, etc.). Then, the liver’s self-repair ability allows liver cells to recover  normal liver function to resume. The biggest problem and weakness of this approach is the long period of liver cell injury (the red bar). In addition, the success rate of most drugs is low while the cost is high; not to mention the long treatment time and severe side effects. In other words, the current treatment approach lacks focus on the recovery process. Chronic liver injury  causes liver fibrosis, cirrhosis and increases the risk of liver cancer greatly.

 

In view of this, chronic liver disease patients should focus on enhancing liver cell recovery and shortening the time with liver damage. We therefore suggest ‘ALT Focused Therapy’:

 

 

The major advantage of ‘ALT Focused Therapy’ is that the most urgent and dangerous problem is tackled first. By first stopping long term injury to liver cells, liver fibrosis and cirrhosis can be prevented, and the chance of liver cancer can be reduced. After liver function is improved, patients can then carry out drug treatment to eliminate the harmful substances in their body gradually. When compared with the current approach, ‘ALT Focused Therapy’ can help patients greatly reduce the time with liver injury (the red bar is shortened significantly).  

 

To carry out ALT Focused Therapy, YHK is a safe and effective formula that can help liver cell recovery. Clinical Research shows that YHK can effectively normalise ALT level and improve liver health quickly (within 10-30 days). It is an ideal options for liver patients who wish to quickly repair their liver cells and improve liver function.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. NAFLD is one of the most common causes of liver disease in the United States. Between 30 and 40 percent of adults in the United States have NAFLD. About 3 to 12 percent of adults in the United States have NASH (a form of NAFLD in which you have inflammation and liver cell damage). [1] Recent research found that NAFLD not only increases the risk of chronic liver diseases such as NASH, l
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
Hit Questions
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us